Australian Prescriber · 2003 · 81 citations · 0 references
PharmacyPharmacologyBioequivalenceClinical PharmacologyPharmaceutical ManufacturingBioequivalence Acceptance CriteriaBioequivalence AssessmentBioequivalence Study DesignGeneric Drug EvaluationPharmaceutical MarketingGeneric Drug Equivalence AssessmentGeneric Drug MarketingGeneric Equivalence StandardsGeneric Product EquivalenceGenerics Equivalence TestingNarrow Therapeutic Index Drug BioequivalenceTherapeutic Equivalence RatingsTherapeutic Index Narrow Drugs
Generic products must be bioequivalent to the innovator brand before they can be marketed in Australia. There are no generic formulations of drugs with a narrow therapeutic index as it would be difficult for them to meet the required standard of bioequivalence. In Australia most generic drugs are marketed with a brand name. Some generic brands are manufactured by the same company that produces the innovator brand of the drug. Although generic brands are usually cheaper the proliferation of brands may cause confusion.